x

Coronavirus

South Africa to Give Johnson & Johnson Vaccine

February 10, 2021

JOHANNESBURG — South Africa’s health minister says the country will begin administering the unapproved Johnson & Johnson vaccine to its front-line health workers next week.

The workers will be monitored to see what protection the J&J shot provides from COVID-19, particularly against the variant dominant in the country.

Health Minister Zweli Mkhize said Wednesday that South Africa scrapped its plans to use the Oxford-AstraZeneca vaccine because it “does not prevent mild to moderate disease” of the variant dominant in South Africa.

Mkhize asserts that the J&J vaccine, which is still being tested internationally, is safe.

He says those shots will be followed by a campaign to vaccinate an estimated 40 million people in South Africa by the end of the year. The minister said the country will be using the Pfizer vaccine and others, possibly including the Russian Sputnik V, Chinese Sinopharm and Moderna vaccines.

RELATED

BEIJING (AP) — The hunt for the origins of COVID-19 has gone dark in China, the victim of political infighting after a series of stalled and thwarted attempts to find the source of the virus that killed millions and paralyzed the world for months.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

On Monday, April 22, 2024, history was being written in a Manhattan courtroom.

PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.

WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.